Literature DB >> 31773023

Strategies to Enhance Radiosensitivity to Heavy Ion Radiation Therapy.

Younghyun Lee1, Ryuichi Okayasu2.   

Abstract

Heavy ion radiation therapy has been increasingly used due to several advantages over low linear energy transfer (LET) photon therapy, but further improvement of its therapeutic efficacy would be necessary. In this review, we summarize effective radiosensitizers for heavy ion radiation therapy and mechanisms associated with the radiosensitization. High LET heavy ions induce more complex and clustered DNA damage than low LET radiation. Inhibition of homologous recombimation repair or nonhomologous end rejoining and dysfunctional cell cycle checkpoint have been reported to sensitize cancer cells to heavy ions. Radiosenstizing agents, including DNA damage response inhibitors, Hsp90 inhibitors, histone acetylase inhibitors, and nanomaterials have been found to enhance cell killing by heavy ion irradiation through disrupted DNA damage response, cell cycle arrest, or other cellular processes. The use of these radiosensitizers could be a promising strategy to enhance the efficacy of heavy ion radiation therapy. ©Copyright 2018 International Journal of Particle Therapy.

Entities:  

Keywords:  DNA repair; carbon ion; heavy ion radiotherapy; radiosensitizers

Year:  2018        PMID: 31773023      PMCID: PMC6871583          DOI: 10.14338/IJPT-18-00014.1

Source DB:  PubMed          Journal:  Int J Part Ther        ISSN: 2331-5180


  58 in total

Review 1.  ATR: an essential regulator of genome integrity.

Authors:  Karlene A Cimprich; David Cortez
Journal:  Nat Rev Mol Cell Biol       Date:  2008-07-02       Impact factor: 94.444

2.  Unrepaired clustered DNA lesions induce chromosome breakage in human cells.

Authors:  Aroumougame Asaithamby; Burong Hu; David J Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-28       Impact factor: 11.205

Review 3.  Poly(ADP-ribose): novel functions for an old molecule.

Authors:  Valérie Schreiber; Françoise Dantzer; Jean-Christophe Ame; Gilbert de Murcia
Journal:  Nat Rev Mol Cell Biol       Date:  2006-07       Impact factor: 94.444

Review 4.  Heavy charged particle radiobiology: using enhanced biological effectiveness and improved beam focusing to advance cancer therapy.

Authors:  Christopher Allen; Thomas B Borak; Hirohiko Tsujii; Jac A Nickoloff
Journal:  Mutat Res       Date:  2011-03-03       Impact factor: 2.433

Review 5.  Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells.

Authors:  P A Marks; V M Richon; R A Rifkind
Journal:  J Natl Cancer Inst       Date:  2000-08-02       Impact factor: 13.506

Review 6.  Roadmap to Clinical Use of Gold Nanoparticles for Radiation Sensitization.

Authors:  Jan Schuemann; Ross Berbeco; Devika B Chithrani; Sang Hyun Cho; Rajiv Kumar; Stephen J McMahon; Srinivas Sridhar; Sunil Krishnan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-09-30       Impact factor: 7.038

7.  The complexity of DNA double strand breaks is a critical factor enhancing end-resection.

Authors:  Hirohiko Yajima; Hiroshi Fujisawa; Nakako Izumi Nakajima; Hirokazu Hirakawa; Penelope A Jeggo; Ryuichi Okayasu; Akira Fujimori
Journal:  DNA Repair (Amst)       Date:  2013-09-13

8.  DNA-PKcs inhibition sensitizes cancer cells to carbon-ion irradiation via telomere capping disruption.

Authors:  Xin Zhou; Xin Zhang; Yi Xie; Kaoru Tanaka; Bing Wang; Hong Zhang
Journal:  PLoS One       Date:  2013-08-27       Impact factor: 3.240

9.  PU-H71, a novel Hsp90 inhibitor, as a potential cancer-specific sensitizer to carbon-ion beam therapy.

Authors:  Huizi Keiko Li; Yoshitaka Matsumoto; Yoshiya Furusawa; Tadashi Kamada
Journal:  J Radiat Res       Date:  2016-05-29       Impact factor: 2.724

10.  VE-821, an ATR inhibitor, causes radiosensitization in human tumor cells irradiated with high LET radiation.

Authors:  Hiroshi Fujisawa; Nakako Izumi Nakajima; Shigeaki Sunada; Younghyun Lee; Hirokazu Hirakawa; Hirohiko Yajima; Akira Fujimori; Mitsuru Uesaka; Ryuichi Okayasu
Journal:  Radiat Oncol       Date:  2015-08-19       Impact factor: 3.481

View more
  1 in total

1.  Editorial: Multifaceted Approaches Combining Low or High LET Radiation and Pharmacological Interventions in Cancer and Radioprotection: From Bench to Bedside.

Authors:  Pankaj Chaudhary; Sandeep Kumar Shukla; Shubhankar Suman
Journal:  Front Oncol       Date:  2022-03-28       Impact factor: 6.244

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.